Physician profile
Robert C Lanoff
NPI 1013945658
$3,034.45
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,317 · 2020: $1,184 · 2021: $533.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.19 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $524.97 | 2019-2021 | |
| Janssen Biotech, INC. | $479.45 | 2019-2021 | |
| Qol Medical, LLC | $356.05 | 2019-2021 | |
| Gilead Sciences, INC. | $228.60 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $188.64 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $133.58 | 2019-2021 | |
| Daiichi Sankyo INC. | $105.33 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.17 | 2019-2021 | |
| Redhill Biopharma INC. | $64.99 | 2020-2021 | |
| Allergan, INC. | $51.68 | 2019-2020 | |
| Braintree Laboratories, INC. | $40.71 | 2019 | |
| Romark Laboratories, Lc | $24.73 | 2020 | |
| Amgen INC. | $19.86 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Concordia Pharmaceuticals INC. | $19.13 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $18.88 | 2020 | |
| Alfasigma USA, INC. | $17.62 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.16 | 2019 | |
| Ucb, INC. | $14.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lanoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.